Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: opty / Re: Communication with USPTO - Update

<is there anything that the USPTO has said that would indicate the contact has impacted their review schedule either positively or negatively?>

We provided the facts. Anything beyond that would be pure speculation.

GLTA, Opty

Share
New Message
Please login to post a reply